Skip to main content
Clinical Trials/NCT01812733
NCT01812733
Completed
Not Applicable

An Observational Study of Quality of Life, Resource Use and Costs Associated With Treatment of Severe Pain - a Comparison of a Combination of Oxycodone and Naloxone (Targiniq) Versus Oxycodone and Laxatives

Mundipharma AB1 site in 1 country37 target enrollmentJune 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pain
Sponsor
Mundipharma AB
Enrollment
37
Locations
1
Primary Endpoint
Quality of Life
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The objective of the non-interventional study is to compare the quality of life, health care resource use and costs between the use of a combination of oxycodone and naloxone (Targiniq) versus oxycodone and laxatives for patients with severe pain, and to evaluate the cost-effectiveness of treatment with Targiniq.

Registry
clinicaltrials.gov
Start Date
June 2013
End Date
June 2015
Last Updated
10 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Quality of Life

Time Frame: 8 Weeks

Two visits performed over 8 weeks

Study Sites (1)

Loading locations...

Similar Trials